Redefining Pre-Clinical Testing in Oncology: Why We Need to Go 3D

Redefining Pre-Clinical Testing in Oncology: Why We Need to Go 3D with Marina Simian Ph.D., Principal Investigator, Instituto de Nanosistemas, Universidad Nacional de San Martín.

Attendees will gain an overview of tissue and organoid model systems, including history and use in specific disease screens. Application to drug development and downstream clinical relevance will be covered.